Back to search
FDAFDA · Food and drugs·Recall number Z-2262-2017

Pressure Injectable ARROW(R) PICC Kit with Chlorag+ard(R) Technology The ArrowEVOLUTIONTM Pressure injectable P1CC with chlorag+ard Antimicrobial and Antithrombogenic Technology is indicated for short-term or long-term peripheral access to the central venous system for intravenous therapy, blood sampling, infusion, pressure injection of contrast media, and allows for central venous pressure monitoring

Published June 14, 2017 · Recall initiated: March 20, 2017

Summary

FDA records medical device Class II recall Z-2262-2017, published June 14, 2017 and initiated March 20, 2017. Recalling firm: Arrow International Inc; Status: Terminated; Reported quantity: 43,394 units; Lot: Material Number ASK-45552-SPH. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Arrow International Inc
Distributor
Nationwide Distribution
Lot
Material Number ASK-45552-SPH
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Pressure Injectable ARROW(R) PICC Kit with Chlorag+ard(R) Technology The ArrowEVOLUTIONTM Pressure injectable P1CC with chlorag+ard Antimicrobial and Antithrombogenic Technology is indicated for short-term or long-term peripheral access to the central venous system for intravenous therapy, blood sampling, infusion, pressure injection of contrast media, and allows for central venous pressure monitoring recalled?

Yes. FDA published recall Z-2262-2017 on June 14, 2017. Reported hazard: Arrow International initiated the recall due to reports of safety cover disengagement and needlestick injury for the BD Eclipse Needle that are packaged with certain Arrow products.

What should I do if I have this product?

Voluntary: Firm initiated · Letter